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Background: Non-alcoholic fatty liver disease, which occurs in people who are not alcohol drinkers, describes
some of the pathogenic conditions that may be in the least characterized by simple steatosis or can be as serious
as non-alcoholic steatohepatitis and cirrhosis. Its mechanistic pathogenesis has been said to arise from insulin
resistance and oxidative stress, which may be compounded by obesity. An experimental model showing single
kidney failure, systemic insulin resistance, obesity and accumulated hepatic fatty acids was created in adult male
rats using high-fat diet manipulation and surgical removal of the left kidney (uni-nephrectomy). This study sought
to identify the impact of these multiple burdens on the liver mitochondrial membrane permeability transition pore
opening, and the possible in vitro effects of the extracts of Clerodendrum volubile and Manihot esculenta leaves on
the membrane permeabilization.
Results: The results indicated that methanolic extract of Clerodendrum volubile leaf inhibited mitochondrial
membrane pore opening in insulin resistance condition or when it is followed by uni-nephrectomy, while ethanolic
extract of Manihot esculenta leaf does the same in insulin resistance condition both prior to and following uni-
nephrectomy.
Conclusion: Since the vegetable extracts were able to abrogate mitochondrial pore opening at low concentrations,
the structural integrity of the mitochondria can possibly be restored over time if treated by the vegetable extracts.
Research efforts should, therefore, be made to harness the drugability of the bioactives of these vegetables for use
in the treatment of non-alcoholic fatty liver disease arising from insulin resistance and renal failure.
Keywords: Insulin resistance, Uninephrectomy, Non-alcoholic fatty liver disease, Mitochondria, Natural products© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made.
* Correspondence: ebenezer.ajayi@uniosun.edu.ng
1Biochemistry Department, Osun State University, Osogbo, Nigeria
2Department of Biochemistry, Ekiti State University, Ado-Ekiti P.M.B.5363.,
Ado-Ekiti, Nigeria
Full list of author information is available at the end of the article
Ajayi et al. Clinical Phytoscience _#####################_ Page 2 of 9Introduction
Multiple burden diseases including, diabetes, obesity,
inflammation, and infection are often consequences of
reduced liver functions [1, 2]. It is widely known that a
reduction in liver function is a result of the bidirectional
relationships in the course of the development of these
diseases [2, 3]. Evidence from established studies in both
humans and animal models suggest that an immediate
reduction in liver functions will likely contribute to
metabolism dysfunction, inflammation and oxidative
stress [4] and thus the development of the disease. The
non-alcoholic fatty liver disease has been strongly linked
to metabolic syndrome [5], and together they are asso-
ciated with a state of chronic low-level inflammation
and stress [6]. It encompasses a wide spectrum of patho-
logical conditions, ranging from simple steatosis to non-
alcoholic steatohepatitis and cirrhosis [7]. Non-alcoholic
steatohepatitis is the most prevalent cause of chronic
liver disease in the Western world and has no approved
treatment [8]. Ischemic hepatopathy, a condition of
acute liver injury caused by insufficient blood flow
caused due to cardiogenic shock (caused by the left-
sided failure of the heart), or other hemodynamic col-
lapses, may lead to massive hepatocellular necrosis [9,
10]. The situation arising from sinusoidal stasis leads to
cell death among other clinical manifestations [11] [12].
Mitochondrial dysfunction and oxidative stress asso-
ciated with metabolic syndrome have been proposed as
major pathophysiological disturbances that contribute to
these pathologies [13, 14].
Mitochondrial dysfunction can cause ATP depletion and
overproduction of reactive oxygen species (ROS), resulting
in protein and lipid oxidation. Oxidative damages to injure
tissues and loss of ATP characterize typical events of cell
death [15]. The mitochondrial membrane potential
dissipates, and the capacity of the organelle to accumulate
Ca2+ becomes abrogated as a consequence of the inhibition
of the respiratory chain. The molecular manipulation of the
mitochondrial pathways has been embraced as a convenient
way to investigate mitochondrial functional integrity [16].
Although mitochondria abundance is not a concern for
functional studies, the certainty of protein purity and struc-
tural integrity are important barriers that can encumber
mitochondrial research [17]. Liver morphological and ultra-
structural integrity may be of concern among kidney donors
who suffer from non-alcoholic fatty liver disease [18, 19].
The mitochondrial membrane permeability transition
(MMPT) represents a sudden increase of inner mito-
chondrial membrane permeability to solutes with mole-
cular mass up to 1500 Da. The MMPT pore is as a result
of the opening of a voltage- and Ca2+-dependent,
spermine-sensitive, high-conductance protein channel
[15, 20]. In its fully open state, the apparent diameter of
the MMPT pore is about 3 nm. When mitochondrialswelling is prolonged, the membrane potential dissipates
as a result of equilibration of the proton gradient across
the inner mitochondrial membrane of ions, following
the further massive release of the Ca2+ stored in the
matrix consequent upon the colloidal osmotic pressure
exerted by the elevated concentration of matrix proteins
[21]. However, it is imperative to note that permeability
transition pore opening can induce the outer mitochon-
drial membrane rupture only through the matrix swel-
ling and therefore cytochrome c and the other
apoptogenic molecules do not exit mitochondria
through the permeability transition pore itself [22].
The permeability transition-based model for the outer
mitochondrial membrane permeabilization is supported by
a number of observations, among which are studies with
experimental models showing evidence of the collapse of
membrane potential before caspase activation [23, 24]; the
protective potential of specific inhibitors against pore open-
ing and several other apoptotic responses [25].
Experimentally, mitochondria swelling can be easily
investigated by light scattering measurements [26]. Also,
when mitochondria swell, their refraction index decreases,
thereby decreasing the intensity of scattered light. The
correlation between the amount of light scattered by a
mitochondrial suspension and the volume of the mito-
chondrial matrix was extensively exploited for qualitative
studies of solute transport across the inner membrane.
The mitochondrial swelling, due to the matrix permeation
to external solutes, was detected as the decrease in the
light scattering of the mitochondrial suspension at 540 nm
[21, 22]. Percentage swelling was calculated based on the
optical density decrease between non-treated and 20 μM
Ca2+ or 200–1400 μg/ml extract treated mitochondria.
Clerodendrum volubile P. Beauv belongs to the family
Lamiaceae. It is found growing in many deciduous forests
across Africa [23]. It is generally known among the
Urhobo and Itsekiri tribes of the Niger-Delta of Nigeria as
‘Obenetete’, Yorubas in Ondo state as ‘marugbo’ [24, 25].
In Nigeria, notably, the southern area, among the Ijaws,
Urhobos and Itsekiris, the leaf is consumed as a delicacy
in foods. In folklore medicine, the plant is useful for the
treatment of several ailments such as diabetes, rheuma-
tism, arthritis, edema and gout [26, 27]. The reported
pharmacological properties of C. volubile leaf includes
anti-inflammatory [27], antioxidants [28, 29], antihyper-
tensive [25, 30], antidiabetic [31, 32], neuroprotective [33],
hepatoprotective [34, 35] and cancer chemopreventive
[36, 37] activities. In a recent study by Erukainure et al.
[38], the antidiabetic effect of acute treatment with ethyl
acetate fraction of C. volubile leaves was investigated and
this property was attributed to the protocatechuic acid
which was observed to be the active compound of the
plant. The authors further reported that this fraction sup-
pressed hyperglycemia in type 2 diabetic rat via synergetic
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cular interactions with a-glucosidase and TNF-a [38]. This
plant is often termed the magic leaf owing to its wide use
in folklore medicine to treat several diseases especially dia-
betes mellitus. Several polyphenolic compounds (flavo-
noids and phenolic acids) have been reported [25, 29, 30,
32] to be present in C. volubile leaves which has been
shown to confer these medicinal and health benefits of
this plant.
Manihot esculenta Crantz, an edible rainforest plant is
a perennial crop native to tropical America with its centre
of origin in North-eastern and Central Brazil [39, 40]. Its
common names include cassava, yuca, tapioca, manioc,
Brazilian arrowroot, dang noi, man sum palung, pearks
sakhoo, huacamote, gbaguda, paki, and ege. The leaves
have also been used against many disorders such as
rheumatism, fever, headache, diarrhea and loss of appetite
[41]. The leaves also possess anti-inflammatory, antipyretic,
anti-diarrhoeal and antihaemorrhoid activities [42]. The
seed oil is found to have antimicrobial activity [43]. The
leaves of the bitter variety of cassava are used to treat
hypertension, headache, and pain [44]. The Cubans com-
monly use cassava to treat irritable bowel syndrome by eat-
ing the paste in excess during treatment [45]. As cassava is
a gluten-free, natural starch, it is embraced in Western
cuisine as a wheat alternative for sufferers of celiac disease
is becoming common [46]. The leaves have also been
shown to have antioxidant properties and hypoglycemic
effect and the ability to close the mitochondrial membrane
permeability transitionn pore in high-fat diet-manipulated,
low-dose STZ-induced diabetic male Sprague-Dawley rats
[47]. A few researchers have reported the antioxidant activ-
ities of cassava tubers including Omar et al. [48], who
showed that the antioxidant activities of organically grown
cassava tubers were higher than those of mineral-base ferti-
lized roots. They found that total phenolic and flavonoid
contents were significantly higher for organic cassava
tubers compared to those grown with inorganic fertilizers.
Increased intake of cassava leaves in diet has also been
reported to decrease the risk of metabolic syndrome in
type 2 diabetic patients [49]. Topical application of ethano-
lic extract of Manihot esculenta to wound area on type 1
diabetic rats was shown to have little effect on
collagenation, re-epithelization and granulation resulting in
no significant effect on wound closure rate compared to
Povidone Iodine [50].
Both plants are use as delicacies and in traditional
medicine and interestingly, certain bioactive compounds
have been identified in these vegetables. The possible
medicinal effects of the plant leaves were studied in our
animal model to see how they would impact MMPT as
they possess known anti-inflammatory, antioxidant, anti-
hypertensive, antidiabetic, neuroprotective, hepatoprotec-
tive and cancer chemopreventive activities. Therefore,owing to the pharmacological potentials of these two
plants (C. volubile and M. esculenta) as used in folklore
medicine in treating several diseases especially diabetes,
we hypothesized that the plants may have the ability to
inhibit liver MMPT pore opening should the liver be
exposed to damage following uni-nephrectomy in the rats,
a response that would be important in diabetes for the
prevention of cell death primarily via the mitochondrial
pathway, and tissue wasting from oxidative stress. In this
present study, we seek to investigate the effects of uni-
nephrectomy on mitochondrial membrane permeability
transition pore status of control and insulin-resistant rats
and determine if their liver mitochondria can still take up
Ca2+ and retain their morphological integrity.
Materials and methods
Plant materials and sample preparation
Matured leaves of Clerodendrum volubile P. Beauv were
purchased at the Oja-Oba Market, Akure, Ondo State,
Nigeria purchased, authenticated and assigned the vou-
cher specimen number FUTA/BIO/0121. The leaves of
red stalk Manihot esculenta (Crantz) were collected at
the botanical garden of the National Institute of Pharma-
ceutical Education and Research, Mohali, Punjab, India,
and given the voucher specimen number NIPER-S/
NPTM/0298. The leaves were air-dried and pulverized
and 50 g of each was soaked in 500ml of 95% methanol
and ethanol, respectively for 24 h. The extracts were
concentrated under pressure using a rotavapor. The
resulting crude extracts were used to assess the extent of
mitochondrial membrane permeability transition in the
liver of insulin resistant, uni-nephrectomized male rats
(Figs. 1 and 2).
Chemicals
Mannitol, sucrose, 4-(2-hydroxyethyl)-1-piperazineetha-
nesulfonic acid (HEPES), ethylene glycol-bis(β-ami-
noethyl ether)-N,N,N′,N′-tetraacetic acid (EGTA),
sodium succinate, and other chemicals were products of
Sigma Chemical Co. (St. Louis, MO USA). Except other-
wise stated, all other solvents used were of analytical
grade.
Experimental animals
Twenty-four Sprague-Dawley rats weighing 180–250 g
were used for the experiment. All animals were main-
tained under standard conditions. The control groups
were fed rodent normal pellet diet ad libitum, while test
groups manipulated for T2DM were fed on high-fat diet.
All experimental procedures were approved by the Insti-
tutional Animal Ethics Committee (IAEC 12/11). The
animals were allowed access to water during a fast for
12 h before sacrifice by decapitation. Experiments were
conducted using 5 animals per group.
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The experimental animals were randomly divided into
six groups: (1) a control non-nephrectomized group fed
normal pellet diet; (2) a uni-nephrectomized group fed
normal diet; (3) a non-nephrectomized ‘sham’ group fed
normal pellet diet (surgically opened, but no ligations
and excision of kidneys were performed); (4) a non-
nephrectomized group fed high fat diet; (5) a uni-
nephrectomized group fed high-fat diet; (6) a high-fat-
diet group subsequently uni-nephrectomized at week 9.
High-fat diet – HFD (58% fat, 25% protein and 17% car-
bohydrate, as a percentage of total kcal) was given to
animals in groups 4–6 ad libitum throughout the study
that lasted 18 weeks (except Group 5 animals, which
commenced HFD feeding immediately after uni-
nephrectomy). This serves as a model for obesity and
insulin resistance [51].
The surgical procedure of uni-nephrectomy
The rats underwent uni-nephrectomy of the left kidney in
an aseptic condition, under ketamine (70mg/kg, i. p.)/ xyla-
zine (7mg/kg, i. p.) anesthesia, before injection with saline
(20ml/kg, s.c.) according to the method described by Holte
et al. [52] with slight modifications [53]. Briefly, a 2 cm
flank incision penetrating the abdominal cavity was made
after the area had been cleaned and shaved. Using forceps,
the kidneys were gently pulled out by holding the perirenal
fat and the renal artery, vein, and ureter tied by a non-
absorbable thread. The left kidney was then excised and the
muscular layer sutured with absorbable suture thread, while
the skin layer was closed with non-absorbable thread. The
animals were left in a solitary cage under the heat of 60W
lamp till recovery from anesthesia.
Isolation of rat liver mitochondria
The liver mitochondrial fraction was prepared according
to the method described by Hogeboom et al. [54] and
Johnson and Lardy [55] with slight modifications. Rat
liver was weighed and washed in isolation buffer con-
taining 210 mM mannitol, 70 mM sucrose, and 1 mM
EGTA in 5mM HEPES-KOH, pH 7.4. A 50% suspension
was prepared by homogenizing the liver in a glass-
Teflon homogenizer. The homogenate was centrifuged
at 2300×g for 5 min twice in a SIGMA-6 K15 refriger-
ated centrifuge to sediment the nuclear fraction and cell
debris and to remove unbroken cells by low-speed cen-
trifugation. The supernatant was centrifuged at 13000×g
for 10 min to pellet the mitochondria. The brown mito-
chondria pellet was washed twice by re-suspending in
isolation buffer containing 0.5% BSA and centrifuged at
12000×g for 10 min. Mitochondria were suspended in
buffer containing 210 mM mannitol, 70 mM sucrose, 5
mM HEPES-KOH, pH 7.4 and 0.5 mM KH2PO4 and
dispensed in microcentrifuge tubes kept on ice.Protein content determination
Protein content was determined using the method of
Lowry et al. [56] using bovine serum albumin as
standard.
Procedure for incubation of mitochondria
One mg/ml liver mitochondrial protein was incubated
with the assay buffer containing 210 mM mannitol, 70
mM sucrose in 5 mM HEPES-KOH, pH 7.4. The incuba-
tion of mitochondria was done with 20 μM rotenone for
3 min (to block the Complex I and limit the source of
electron supply to the electron transport system to Com-
plex II) prior to the addition of 12 mM CaCl2, 30 s after
which the assay was energized by 50mM sodium succi-
nate [57].
Assessment of mitochondrial permeability transition
Mitochondrial swelling as the indicator of MMPT was
spectrophotometrically measured by continuous time scan
of the change in absorbance at 540 nm for 12min [58].
Transmission electron microscopy (TEM) of mitochondria
For TEM (FEI Tecnai G2 F20, Thermo Scientific™, USA),
mitochondria pellets were recovered from − 80 °C freezer
and dispersed in 20% DMSO containing 1% FAF-BSA.
Mitochondria were fixed in 2.5% glutaraldehyde pre-
pared in sodium phosphate buffer (pH 7.4, 1:1 v/v) and
kept at 4 °C overnight. This was washed with 500 μl
sodium phosphate buffer and spun at 7000×g for 10
min. Stepwise dehydration was achieved using 20%, 40%,
70% and 90% ethanol while spinning at the same speed
each time. Final dehydration was done with 100% etha-
nol at 4 °C over 15 min. The mitochondria pellet was
dispersed in the embedding medium (1:3, 2:2, 3:1 and 4:
0, v/v resin: ethanol) for 15 min, respectively spinning
each time as with the dehydration steps. At absolute
resin embedding, the spur was incubated at 65 °C over-
night to achieve solidification. The block was then
removed for processing by tissue sectioning to 60 nm
using a glass knife on an RMC Boekeler PT-PC Power-
Tome ultramicrotome. The ultra-thin sections were
mounted on Pioloform filmed copper grids prior to
staining with 4% uranyl acetate prepared in 50% metha-
nol. Ultrathin sections were examined using FEI Tecnai
G2 F20 transmission electron microscope at 120 KV,
and digital micrographs were captured by a Gatan CCD
camera.
Statistical analysis
The results were presented in the form of percentages.
The data were analyzed by ANOVA (SPSS 20) at a sig-
nificance level of p-value less than 0.05 and if significant,
the comparisons between the groups were performed
using Tukey’s post hoc test.
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The degree of Ca2+ uptake (percentage induction of the
pore opening) exhibited by the mitochondria significantly
varied across the groups (Table 1; Additional files 1, 2, 3,
4, 5, 6, 7, 8, 9, 10, 11 and 12). Methanolic extract of
Clerodendrum volubile leaf induced opening in normal
pellet diet-fed, uni-nephrectomized rats (Additional file 3)
at 200 μg/ml, and in high-fat-diet-fed at 200 μg/ml,
600 μg/ml, and 1000 μg/ml, but showed late-onset open-
ing around 15 s at 1400 μg/ml (Additional file 4). Similarly,
ethanolic extract of Manihot esculenta leaf induced pore
opening in high-fat-diet-fed rats at 200 μg/ml and 600 μg/
ml (Additional file 10) and in uni-nephrectomized, high-
fat-diet-fed only at 1400 μg/ml (Additional file 11). These
observations show that the crude vegetable extracts of
these edible plants are capable of modulating mitochon-
drial pore opening in rat liver.
From the TEM images, the observations in the differ-
ences in the architectural ultrastructure of the double
membranes were compared to that of the mitochondria in
the apparently normal control group. Following similar pre-
paration steps for each sample, same volume of mitochon-
dria pellets were fixed, ultra-thin slices of the same size
were prepared, stained and the images were taken at the
same resolution to make comparison easy. Simple observa-
tion of the TEM images showed the state of both the inner
and outer mitochondrial membranes. The modulation of
pore opening by the extracts followed a concentration-
dependence, revealing which concentration may be consid-
ered efficient in preserving the mitochondrial against possi-
ble oxidative damage, even if the native state was not
recovered. The TEM images revealed the morphological
changes of the mitochondrial population across the study
groups (Fig. 3). These observations confirmed that high-fatTable 1 Percentage induction of mitochondrial membrane pore op





















































































Cv Clerodendrum volubile P. Beauv, Me Manihot esculenta Crantz (red stalk), NPD-C N
Diet-fed, Uni-nephrectomized, HFD-Sham High Fat Diet-fed, surgically opened, non-
nephrectomized before High Fat Diet-fed, HFD-UNX High Fat Diet-fed before uninep
groups at p < 0.05. bSignificantly different from TA effect across all groups at p< 0.0diet lifestyle and/or uni-nephrectomy predispose to the
development of non-alcoholic fatty liver disease, which
invariably affects the structural integrity and functional
capacity of liver mitochondria (Fig. 3: B-F). Following the
mitochondrial isolation protocol, no whole cells or nuclei
were seen by TEM and the mitochondria were essentially
free of other contaminants. Only a small membranous arti-
fact attributable to microsomes was observed. Across the
treated groups, the isolated mitochondria population dis-
played morphological signs of damage to differing degrees.
The observations from the in vitro study support the
hypothesis that the extracts may be able to reverse damages
caused by the development of non-alcoholic fatty liver dis-
ease in insulin-resistance with or without nephrectomy.
A low-amplitude swelling was observed in the energized
mitochondria by the extracts in the presence of exogenous
CaCl2. The ability of Clerodendrum volubile leaf extract to
abrogate the progression of mitochondrial membrane
depolarization and leakage only in uni-nephrectomized
normal rats at high concentrations, and in insulin-resistant,
uni-nephrectomized rats at all concentrations suggests its
protective role against complications that may arise from
nephrectomy in normal and previously insulin-resistant
conditions before kidney donation or damage. This obser-
vation is similar to the submissions of [59] that insulin
resistance (IR) predisposes to the development of chronic
kidney disease (CKD) in non-diabetic patients, and those
with mild-to-moderate stage CKD. It is also interesting that
the aqueous extract of C. volubile leaves has earlier been
identified to contain phytochemicals that exert antidiabetic
effects in Wistar rats [32].
Inhibition of the mitochondrial membrane pore opening
by the ethanolic extract of Manihot esculentaleaf was
observed at intermediate concentrations in high-fat-diet-fedening in rat liver mitochondria incubated with methanolic
t esculenta leaf, in vitro
HFD UNX-HFD HFD-UNX
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nephrectomized, HFD High Fat Diet-fed, uni-nephrectomized, UNX-HFD Uni-
hrectomized. asignificantly different when compared with NTA effect across all
5
Fig. 1 Clerodendrum volubile. Molehin et al., 2017 [29]. Molehin OR,
Oloyede OI, Boligon AA. Comparative study on the phenolic
content,antioxidant properties and HPLC fingerprinting of the
extracts of Clerodendrum volubile. P. Beauv. J App Pharm Sci.
2017a; 7:135–140
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high-fat-diet-fed rats, and at all the extract concentrations in
the high-fat-diet-fed, uni-nephrectomized rats. These find-
ings were consistent with the results of another study which
revealed that the crude ethanolic extract of Manihot escu-
lenta leaf inhibited mitochondrial pore opening in both nor-
mal and type 2 diabetic Sprague-Dawley rats, both in vivo
and in vitro, which may be due to the significant antioxidantFig. 2 Manihot esculenta Crantz. From: Richard Wong Garden &
Woodwork In: Poisonous Yet Nutritious [64]. (http://
rwgardenwoodwork.blogspot.com/2017/07/)properties of the extract [47, 60]. These observations suggest
that the protective role of Manihot esculenta leaf extract can
be harnessed both when insulin-resistance develops follow-
ing kidney donation or damage, and when there has been
insulin resistance before nephrectomy.
As depicted from the TEM results (Fig. 3), it can be
observed that high-fat diet resulted in the shrinking of
mitochondria while nephrectomy resulted in the swelling
of mitochondria. The latter event, which is characteristic
of fatty liver, would ultimately lead to mitochondrial pore
opening that will lead to the escape of calcium into the
cytosol, marking the progression of cell suicide via the
mitochondrial pathway. Previous research findings have
established increased lipid peroxidation and decreased
active biliary transport in hepatocytes following
nephrectomy. This is usually a result of uremic toxins
affecting liver cells, probably by competing at the hepato-
cellular level, with the endogenous substances, which are
normally excreted in urine [61] Damage to the liver, a
remote organ, has also been reported following renal fail-
ure, especially when insulin resistance is present [62].
Indeed, according to Filozof et al. [8], accumulation of fat
in the liver exerts several cellular and metabolic effects
that can, in the long run, culminate in steatohepatitis and
fibrosis. These include a high preponderance of apoptotic
cell death in hepatocytes, mitochondrial dysfunction char-
acterized by the increased generation of reactive oxygen
species, accompanied by lipid peroxidation of membranes
structures as well as a cascade of activation of pro-
inflammatory genes, which will further exacerbate the
induction of several other inflammatory mediators
involved in the development of liver fibrosis.Conclusions
We showed uni-nephrectomy mimicked the situation of
kidney donation, especially in the presence of insulin
resistance developed by a life style of high fat diet. We
also endeavored to see if there is/are any possible attend-
ing effect on the liver mitochondria architecture, and
those of the two extracts on the mitochondrial membrane,
in vitro by the simple swelling assay and ex vivo using
TEM. As the vegetable extracts were able to abrogate
mitochondrial pore opening at low concentrations, the
structural integrity of the mitochondria can possibly be
restored over time if treated by the vegetable extracts. This
can be a good recommendation for insulin-resistant, living
kidney donors and renal cell carcinoma patients, who may
be predisposed to non-alcoholic fatty liver disease
following nephrectomy. Thus, the knowledge about the
ability of these vegetable extracts to modulate mitochon-
drial pore opening which precedes the occurrence of cell
death can be applied for useful drug development for the
management of the complications of insulin-resistance,
Fig. 3 TEM images of ultra-thin sections showing the morphological architecture of insulin resistant. uni- nephrectomized male rat liver
mitochondria. a NPD-C: Normal Pellet Diet-fed,Control, non-nephrectomized; b NPD-UNX: Normal Pellet Diet-fed, Uni-nephrectomized; c HFD-
Sham: High Fat Diet-fed, surgically opened, non-nephrectomized; d HFD: High Fat Dietfed,uni-nephrectomized; e UNX-HFD: Uni-nephrectomized
before High Fat Diet-fed; f HFDUNX:High Fat Diet-fed before uni-nephrectomized. The TEM images are also shown in the samesection size
(0.2 μm) and magnification (× 5000) using high resolution transmission electron microscope (HRTEM, 120 kV)
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by nephrectomy [63].
Limitations
This study was carried out in vitro. The observations
may not be extended to explain what might happen
in vivo as the administration of the plant extract by oral
gavage may show a different response in the animals.
Additional files
Additional file 1: Liver MMPT pore opening in the normal male rat using
the methanolic extract of Clerodendrum volubile leaf, in vitro (TIF 7009 kb)
Additional file 2: Liver MMPT pore opening in ‘Sham’ male rat using the
methanolic extract of Clerodendrum volubile leaf, in vitro (TIF 7438 kb)
Additional file 3: Liver MMPT pore opening in normal diet fed, uni-
nephrectomized male rat using the methanolic extract of Clerodendrum
volubile leaf, in vitro (TIF 7094 kb)
Additional file 4: Liver MMPT pore opening in high-fat diet fed male
rat using the methanolic extract of Clerodendrum volubile leaf, in vitro
(TIF 7363 kb)
Additional file 5: Liver MMPT pore opening in uni- nephrectomized,
high fat diet fed male rat using methanolic extract of Clerodendrum
volubile leaf, in vitro (TIF 7016 kb)
Additional file 6: Liver MMPT pore opening in high-fat diet fed uni-
nephrectomized male rat using the methanolic extract of Clerodendrum
volubile leaf, in vitro (TIF 7105 kb)
Additional file 7: Liver MMPT pore opening in the normal male rat using
the ethanolic extract of Manihot esculenta leaf, in vitro (TIF 6993 kb)
Additional file 8: Liver MMPT pore opening in ‘Sham’ male rat using
the ethanolic extract of Manihot esculenta leaf, in vitro (TIF 7499 kb)
Additional file 9: Liver MMPT pore opening in normal diet fed, uni-
nephrectomized male rat using the ethanolic extract of Manihot esculenta
leaf, in vitro (TIF 7294 kb)
Additional file 10: Liver MMPT pore opening in high-fat diet fed, male rat
using the ethanolic extract of Manihot esculenta leaf, in vitro (TIF 7221 kb)
Additional file 11: Liver MMPT pore opening in uni- nephrectomized,
high-fat diet fed, male rat using the ethanolic extract of Manihot
esculenta leaf, in vitro (TIF 7265 kb)
Additional file 12: Liver MMPT pore opening in high-fat diet fed, in uni-
nephrectomized male rat using the ethanolic extract of Manihot esculenta
leaf, in vitro (TIF 7114 kb)Abbreviations
ATP: Adenosine Triphosphate; BSA: bovine serum albumin; CaCl2: Calcium
chloride; CKD: chronic kidney disease; Cv and MLE: Clerodendrum volubile leaf
extract; EGTA: Ethylene glycol-bis(β-aminoethyl ether)-N,N,N′,N′- tetraacetic
acid; HEPES: 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid; HFD: high fat
diet; HFD: High Fat Diet-fed, uni-nephrectomized; HFD-Sham: High Fat Diet-
fed, surgically opened, non-nephrectomized; HFD-UNX: High Fat Diet-fed
before uni- nephrectomized; KH2PO4: potassium hydroxide; KOH: potassium
hydroxide; Me and CLE: Manihot esculenta leaf extract; MMPT: Mitochondrial
Membrane Permeability Transition; NPD-C: Normal Pellet Diet-fed, Control,
non-nephrectomized; NPD-UNX: Normal Pellet Diet-fed, Uni-nephrectomized;
NTA: No triggering agent, negative control (no treatment with exogenous
calcium, only energized with sodium succinate); ROS: reactive oxygen
species; SPSS: Statistical Package for Social Sciences; STZ: Streptozotocin;
T2DM: Type 2 diabetes mellitus; TA: Triggering agent, positive control
(treatment with exogenous calcium to represent calcium overload which
triggers pore opening); TEM: Transmission electron microscopy; TNF-
α: Tumor necrosis factor alpha; Treatment groups: Extracts tested at different
concentrations (200, 600, 1000 and 1400 μg/ml) for each group.; UNX-
HFD: Uni-nephrectomized before High Fat Diet-fed
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